Snowball logo
logo
PLRZ

Polyrizon Ltd. Ordinary Shares

PLRZ • NASDAQ
$8.9573+$0.2322  (2.66%)
Estimate
EPS
-4.82
Beta
1.693
Growth
Net income, YoY
-1,608,939.55%
FCF, YoY
-214,710.75%
About the company
Ticker
PLRZ
ISIN
IL0011814113
Country
Israel
Sector (GICS)
Healthcare
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It also develops PL-14, a nasal allergies blocker; and PL-16 for influenza blockers. Polyrizon Ltd. was incorporated in 2005 is headquartered in Ra'anana, Israel.

Frequently asked questions

What sector does Polyrizon Ltd. Ordinary Shares (PLRZ) operate in?

Polyrizon Ltd. Ordinary Shares belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Polyrizon Ltd. Ordinary Shares (PLRZ) current stock price?

As of the latest data, Polyrizon Ltd. Ordinary Shares stock price is $8.96, with a previous close of $8.73. Polyrizon Ltd. Ordinary Shares gained $0.23 in the last trading session, representing a 2.66% increase.

What is Polyrizon Ltd. Ordinary Shares (PLRZ) current market capitalization?

Polyrizon Ltd. Ordinary Shares market cap is approximately 21.75 million.

What is Polyrizon Ltd. Ordinary Shares (PLRZ) Earnings Per Share (EPS)?

The trailing EPS is -$4.82.

What is Polyrizon Ltd. Ordinary Shares (PLRZ) EBITDA?

Polyrizon Ltd. Ordinary Shares EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -4.17 million.

Does Polyrizon Ltd. Ordinary Shares (PLRZ) pay dividends?

No. Polyrizon Ltd. Ordinary Shares does not pay a dividend.

What is Polyrizon Ltd. Ordinary Shares (PLRZ) beta (volatility) score?

Polyrizon Ltd. Ordinary Shares has a beta of 1.693, suggesting it is more volatile than the market.